| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.13M | 102.13M | 121.52M | 109.33M | 120.52M | 122.85M |
| Gross Profit | -7.68M | -7.45M | 2.05M | 4.01M | -222.00K | -20.52M |
| EBITDA | -64.27M | -60.38M | -75.66M | -12.18M | -39.82M | -38.54M |
| Net Income | -72.58M | -72.58M | -90.42M | -26.64M | -60.49M | -52.81M |
Balance Sheet | ||||||
| Total Assets | 250.12M | 250.12M | 278.50M | 321.65M | 313.53M | 405.11M |
| Cash, Cash Equivalents and Short-Term Investments | 7.47M | 7.47M | 9.72M | 13.89M | 10.17M | 17.23M |
| Total Debt | 154.13M | 154.13M | 171.85M | 121.17M | 100.36M | 206.10M |
| Total Liabilities | 235.69M | 235.69M | 260.68M | 311.39M | 282.02M | 313.23M |
| Stockholders Equity | 14.43M | 14.43M | 17.82M | 10.26M | 31.51M | 91.88M |
Cash Flow | ||||||
| Free Cash Flow | -29.48M | -29.48M | -39.87M | -20.48M | -38.98M | -111.12M |
| Operating Cash Flow | -29.28M | -29.28M | -38.45M | -20.21M | -38.96M | -111.07M |
| Investing Cash Flow | -5.57M | -5.57M | 26.00K | 14.77M | 33.06M | 6.64M |
| Financing Cash Flow | 32.49M | 32.49M | 34.14M | 8.96M | -983.00K | 92.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$284.74M | 2.33 | 19.34% | ― | -3.12% | 1.92% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | HK$113.85M | 40.00 | 1.83% | ― | 5.99% | -74.29% | |
55 Neutral | HK$86.40M | 18.78 | 1.89% | ― | -20.10% | -74.16% | |
49 Neutral | HK$305.70M | -7.63 | -23.55% | ― | 10.42% | 11.14% | |
47 Neutral | HK$480.00M | -8.52 | -346.03% | ― | -24.25% | 49.22% | |
45 Neutral | HK$100.00M | 15.15 | 2.37% | ― | -1.65% | 230.00% |
Dimmi Life Holdings’ wholly owned subsidiary Dimmi Chain has signed a strategic cooperation framework agreement with its first partner in the electronic atomization industry, under which it will act as the partner’s primary raw material supplier in China and collaborate on new technology development. The arrangement formalizes a long‑term strategic partnership aimed at optimizing resource allocation and strengthening both parties’ competitive positions, but also triggers a disclosure requirement under Hong Kong listing rules because the performance deposit Dimmi Chain must pay the partner qualifies as a significant advance to an entity relative to the group’s assets.
The most recent analyst rating on (HK:1667) stock is a Hold with a HK$0.49 price target. To see the full list of analyst forecasts on Dimmi Life Holdings Limited stock, see the HK:1667 Stock Forecast page.
Dimmi Life Holdings Limited reported its interim financial results for the six months ended September 30, 2025, showing a 15.3% decrease in revenue from continuing operations compared to the same period in 2024. Despite a reduction in losses from continuing operations, the company decided not to declare an interim dividend, indicating a cautious approach amidst challenging financial performance.
The most recent analyst rating on (HK:1667) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Dimmi Life Holdings Limited stock, see the HK:1667 Stock Forecast page.
Dimmi Life Holdings Limited has announced a board meeting scheduled for November 28, 2025, to discuss and approve the interim financial results for the six months ending September 30, 2025. The meeting will also consider the recommendation of an interim dividend, indicating the company’s commitment to maintaining shareholder value.
The most recent analyst rating on (HK:1667) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Dimmi Life Holdings Limited stock, see the HK:1667 Stock Forecast page.